Laura Sepp-Lorenzino Insider Trading
Get free email notifications about insider trading for Laura Sepp-Lorenzino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Laura Sepp-Lorenzino. Laura Sepp-Lorenzino is a EVP, Chief Scientific Officer in Intellia Therapeutics, Inc. ($NTLA) and a Director in Taysha Gene Therapies, Inc. ($TSHA).
Address: C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130 CAMBRIDGE 02139 MA
Companies in which Laura Sepp-Lorenzino is an Insider
Intellia Therapeutics, Inc.
Trading Symbol: NTLAIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Laura Sepp-Lorenzino: EVP, Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 05 2021
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Taysha Gene Therapies, Inc.
Trading Symbol: TSHAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Laura Sepp-Lorenzino: Director
Holdings: 0 shares
Latest Transaction: Jun 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Laura Sepp-Lorenzino
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | TSHA | Taysha Gene Therap ... | Sepp-Lorenzino Laura | Director | Option Exercise | A | 25.04 | 15,500 | 388,120 | 15,500 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Sepp-Lorenzino Laura | EVP, Chief Scientif ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
Mar 05 2021 | NTLA | Intellia Therapeut ... | Sepp-Lorenzino Laura | EVP, Chief Scientif ... | Option Exercise | A | 57.71 | 84,000 | 4,847,640 | 84,000 | |
Nov 24 2020 | TSHA | Taysha Gene Therap ... | Sepp-Lorenzino Laura | Director | Option Exercise | A | 21.77 | 31,000 | 674,870 | 31,000 | |
Nov 24 2020 | TSHA | Taysha Gene Therap ... | Sepp-Lorenzino Laura | Director | Option Exercise | A | 21.77 | 31,000 | 674,870 | 31,000 | |
Mar 04 2020 | NTLA | Intellia Therapeut ... | Sepp-Lorenzino Laura | EVP, Chief Scientif ... | Option Exercise | A | 13.40 | 135,000 | 1,809,000 | 135,000 | |
Jun 04 2019 | NTLA | Intellia Therapeut ... | Sepp-Lorenzino Laura | EVP, Chief Scientif ... | Option Exercise | A | 14.25 | 150,000 | 2,137,500 | 150,000 |